Galectin Therapeutics

US-based, clinical stage, public biopharma developing galectin protein targeting therapeutics for Fibrotic diseases and cancer

placeNorcross, Georgia, United States calendar_todayFounded 2000 groups12 employees language galectintherapeutics.com

Registered entities

Innovation

9 patent families (9 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,654 times.

YearFilings
20147
20156
20167
20175
20187
20194
20205
20215
20221
20231
20251
20261
Coming soon